2019 Hyundai Ioniq Limited
1.6 L • 4 • 104 hp • FWD • AT
KMHC05LC6KU124829
Sales history: 1
Highlights
Condition
Not provided
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
1.6 L • 4 • 104 hp • FWD • AT
Odometer
41,794 mi ≈ 67,261 km
Primary damage
Rear end
Docs
Cert Title
Extra
Auction
VIN
KMHC05LC6KU124829
Lot number
80346933
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Dallas, TX
Description
Fuel type
Hybrid
Body color
White
Body type
Hatchback
Trim
Limited
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Hyundai models
2019 Hyundai Ioniq Limited • 1.6 L • 4 cyl • 104 hp • FWD • Automatic • Copart Lot: 80346933 • VIN: KMHC05LC6KU124829
Find out more about this 2019 Hyundai Ioniq Limited, available at the Copart salvage car auction as lot #80346933 in Dallas, TX. This car has Rear end main damage. It is listed with start condition code. Odometer shows 41,794 mi. This White Hyundai Ioniq Hatchback is equipped with Hybrid 1.6 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for KMHC05LC6KU124829 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
